{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n Apolipoprotein A‐IV (APOA4) is a multifunctional protein that plays integral roles at the interface of dietary fat absorption, plasma lipid metabolism, inflammation, and glucose homeostasis. Synthesized predominantly in the small intestine in response to fat intake, APOA4 is secreted on nascent chylomicrons and modulates plasma triglyceride and cholesterol levels by influencing chylomicron particle size and postprandial clearance without necessarily altering lipoprotein particle number."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " Genetic variants in APOA4 have been linked to differences in plasma triglyceride concentrations and coronary heart disease risk, supporting an antiatherogenic function."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " In addition, APOA4 contributes to systemic metabolic regulation through anti‐inflammatory effects; administration of the protein in experimental colitis models delays disease onset and reduces inflammation by inhibiting endothelial P‐selectin expression and limiting leukocyte–platelet adhesion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Moreover, APOA4 can enhance glucose‐stimulated insulin secretion from pancreatic islets, thereby contributing to improved glucose tolerance under both normal and metabolic stress conditions."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Transcriptional regulation by nuclear receptors—such as the direct activation of the APOA4 promoter by ERRα in intestinal enterocytes—further positions APOA4 as a key mediator of fat transport and metabolic homeostasis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In models of atherosclerosis, expression of APOA4 in apoE‐deficient mice diminishes lesion development, and recent work has even identified APOA4 as an endogenous ligand for platelet integrins that can inhibit platelet aggregation and thrombosis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " Collectively, these findings underscore the diverse and critical functions of APOA4 in coupling intestinal fat absorption with whole‐body lipid handling, anti‐inflammatory defense, and the regulation of glucose homeostasis.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Alison B Kohan, Fei Wang, Xiaoming Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-IV regulates chylomicron metabolism-mechanism and function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00225.2011"}], "href": "https://doi.org/10.1152/ajpgi.00225.2011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22207575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22207575"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Melissa A VerHague, Dongmei Cheng, Richard B Weinberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-IV expression in mouse liver enhances triglyceride secretion and reduces hepatic lipid content by promoting very low density lipoprotein particle expansion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.113.301948"}], "href": "https://doi.org/10.1161/ATVBAHA.113.301948"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24030551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24030551"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Philippa J Talmud, Emma Hawe, Steve Martin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/11.24.3039"}], "href": "https://doi.org/10.1093/hmg/11.24.3039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12417525"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12417525"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Wai-man R Wong, Emma Hawe, Lai K Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.RES.0000069688.94567.7A"}], "href": "https://doi.org/10.1161/01.RES.0000069688.94567.7A"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12676816"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12676816"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Thorsten Vowinkel, Mikiji Mori, Christian F Krieglstein, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-IV inhibits experimental colitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI21233"}], "href": "https://doi.org/10.1172/JCI21233"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15254593"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15254593"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Fei Wang, Alison B Kohan, Tammy L Kindel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin secretion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1201433109"}], "href": "https://doi.org/10.1073/pnas.1201433109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22619326"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22619326"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Julie C Carrier, Geneviève Deblois, Céline Champigny, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M410337200"}], "href": "https://doi.org/10.1074/jbc.M410337200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15466464"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15466464"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Steve Martin, Viviane Nicaud, Steve E Humphries, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochim Biophys Acta (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0925-4439(03)00033-4"}], "href": "https://doi.org/10.1016/s0925-4439(03"}, {"type": "t", "text": "00033-4) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12697303"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12697303"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Delia Recalde, Maria A Ostos, Edgar Badell, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/01.ATV.0000119353.03690.22"}], "href": "https://doi.org/10.1161/01.ATV.0000119353.03690.22"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14751811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14751811"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Xiaohong Ruby Xu, Yiming Wang, Reheman Adili, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41467-018-05806-0"}], "href": "https://doi.org/10.1038/s41467-018-05806-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30190457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30190457"}]}]}]}